Completed Public Health & Healthcare Infection & Immunity

Thailand Africa and Asia Programme - GBP Core

In plain English

AI plain-English summary

For 40 years, a Wellcome-funded research programme based in Thailand has changed how doctors worldwide treat malaria, melioidosis, and tick-borne infections. Now entering its fifth decade, the programme is shifting focus from discovery to delivery—ensuring that proven treatments and diagnostic tools actually reach the people who need them. The problem is stark: infectious diseases drive much of the health gap between rich and poor countries. Effective treatments exist, but translating research into policy and practice remains slow. This programme aims to close that gap by embedding health economics analysis into every project, and by building direct partnerships with policymakers, hospitals, and local communities across Thailand, Africa, and Asia. If successful, the programme will accelerate the adoption of affordable, deployable solutions for disease prevention, diagnosis, and patient management. That could mean fewer deaths from treatable infections, shorter hospital stays, and lower healthcare costs—particularly in low-income settings where every intervention must be cost-effective. The work also strengthens the research capacity of local institutions, so that partner-led programmes can continue translating evidence into policy long after this grant ends.

View original technical description
The Wellcome Thailand AAP has conducted high quality impactful research for 40 years on infectious diseases of major public health concern, leading to the widespread adoption of new approaches and treatments for many of them including malaria, melioidosis, and rickettsial infections. In our fifth decade we will focus on ensuring sustainable impact and influence on policymakers by strengthening our research network and developing the capabilities of our partner institutions. Our vision is to: 1. Through research continue to address public health problems with regional and global relevance, using cutting edge approaches to seek affordable and deployable solutions to disease prevention, diagnosis and patient management. 2. Maximise our public health research’s uptake and impact, incorporating health economics analysis and goal-driven engagement with policymakers, national academic institutions, hospitals, industry partners, communities and the general public. 3. Work with our local host institutions to increase their national and global impact by integrating activities including training programmes, joint research projects, and supporting partner-led programmes to translate research into policy and practice. Our goal is to improve life quality and expectancy by reducing the adverse impact of infectious diseases, which account for much of the disparity in health metrics between low and high income countries.

View the original record at the funder ↗

Researchers

Kesinee Chotivanich (EPMC Awardee)Mallika Imwong (EPMC Awardee)Phaik Yeong Cheah (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Thailand Major Overseas Programme Core Grant Renewal 2010 to 2015.
Vietnam Africa Asia Programme Core Grant Renewal, 2022 to 2029
Cross-AAPs acceleration of genomics for escalating infectious diseases
Africa Health Research Institute - Core Renewal 2023-30 (GBP)
Viet Nam Major Overseas Programme Core Grant Renewal 2010-2015.

Original classification

Africa and Asia Programmes

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.